Kabra Drugs Limited (BOM:524322)

Kabra Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	212.99	26.71	0.03	0.01	0.1
Cash & Short-Term Investments	212.99	26.71	0.03	0.01	0.1
Cash Growth	697.44%	90453.72%	133.67%	-87.10%	-10.75%
Accounts Receivable	6.01	6	6	6	12.55
Receivables	6.01	6.44	6.44	6.72	13.26
Other Current Assets	32.62	12.33	0.33	0.33	0.33
Total Current Assets	251.62	45.48	6.8	7.06	13.69
Property, Plant & Equipment	0.44	-	-	-	0.1
Other Long-Term Assets	0.23	0.23	0.23	0.23	0.23
Total Assets	252.29	45.72	7.04	7.3	14.02
Accounts Payable	-	-	-	-	1.87
Short-Term Debt	4.37	17.08	13.82	10.26	9
Other Current Liabilities	1.37	17.8	0.53	0.97	5.22
Total Current Liabilities	5.74	34.89	14.35	11.23	16.1
Long-Term Deferred Tax Liabilities	0.01	-	-	-	-
Other Long-Term Liabilities	-	-	0	0	-
Total Liabilities	5.74	34.89	14.35	11.23	16.1
Common Stock	237.08	43.89	43.89	43.89	43.89
Retained Earnings	9.47	-58.56	-51.2	-47.82	-45.96
Comprehensive Income & Other	-0	25.5	-	-	-
Shareholders' Equity	246.55	10.83	-7.31	-3.93	-2.08
Total Liabilities & Equity	252.29	45.72	7.04	7.3	14.02
Total Debt	4.37	17.08	13.82	10.26	9
Net Cash (Debt)	208.62	9.63	-13.79	-10.25	-8.91
Net Cash Growth	2067.42%	-	-	-	-
Net Cash Per Share	19.02	2.19	-3.14	-2.33	-2.03
Filing Date Shares Outstanding	18.74	4.39	4.39	4.39	4.39
Total Common Shares Outstanding	18.74	4.39	4.39	4.39	4.39
Working Capital	245.88	10.6	-7.54	-4.16	-2.41
Book Value Per Share	13.15	2.47	-1.67	-0.90	-0.47
Tangible Book Value	246.55	10.83	-7.31	-3.93	-2.08
Tangible Book Value Per Share	13.15	2.47	-1.67	-0.90	-0.47
Machinery	-	1.66	1.66	1.66	1.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.